Chemotherapy in Treating Patients With Advanced Solid Tumors
A Phase I Study of Cyclic Oral Administration of SCH 52365 for 21 of 28 Days in Patients With Advanced Solid Malignancies
Sponsor: Cancer Therapy and Research Center, Texas
This PHASE1 trial investigates Unspecified Adult Solid Tumor, Protocol Specific and is currently completed. Cancer Therapy and Research Center, Texas leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
Jul 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Therapy and Research Center, Texas
- National Cancer Institute (NCI)
- The University of Texas Health Science Center at San Antonio
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Fort Sam Houston, United States
- • San Antonio, United States